Project Grant R01CA312709
Award Date 6/1/26
Completion Date 5/31/31
Dollars Obligated $645K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Chapel Hill, NC 27599, USA
Similar Awards
- Federal Project Grant Award Summary The University of North Carolina at Chapel Hill received a $197,747 Project Grant awarded on August 6, 2025, by the National Cancer Institute under the Cancer Research Manpower program (CFDA 93.398). The I-ACCESS (Improving Affordability in Cancer Care Through Economic Screening and Support) initiative will develop and pilot a screening assessment and referral program designed to proactively identify cancer-related financial hardship in patients across diverse...
- Federal Grant Award Summary The University of North Carolina at Chapel Hill received a $2.75 million Project Grant from the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393) to conduct research on improving cervical precancer treatment outcomes in women living with HIV in Africa. The award, effective September 15, 2025, through August 31, 2030, will fund a pilot Phase IIA randomized placebo-controlled trial investigating the safety, adherence, and...
- Federal Project Grant Award Summary Weill Medical College of Cornell University received a $702,461 Project Grant from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393), effective June 1, 2026 through May 31, 2031. The award funds a hybrid implementation-effectiveness trial designed to evaluate the COLPO (Clear Communication, Optimize Follow Up, Leverage Education, Promote Prevention, Outreach to Increase Awareness) educational intervention,...
- Federal Project Grant Award Summary The University of North Carolina at Chapel Hill received a $207,802 Project Grant from the National Cancer Institute under the Cancer Detection and Diagnosis Research Program (CFDA 93.394), effective May 1, 2026 through April 30, 2029. This award supports the development of multiplexed multiscale imaging technologies and automated analysis systems to advance cellular immunotherapy research. The project will deliver two primary products: (1) development of...
- The National Cancer Institute (NCI) awarded a $621,406 Project Grant on August 1, 2025, under the 21st Century Cures Act - Beau Biden Cancer Moonshot program (CFDA 93.353) to Fred Hutchinson Cancer Center to evaluate a multilevel intervention designed to improve follow-up colonoscopy completion rates among patients with abnormal Fecal Immunochemical Tests (FIT) in safety-net healthcare settings. The PROACT (Promoting Follow-up of Abnormal Colorectal Cancer Screening Tests through Multilevel...
- Federal Grant Award Summary Duke University's Office of Research Administration received a $415,257 Project Grant award from the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395) on April 24, 2026, with completion targeted for March 31, 2028. The research project addresses colorectal cancer (CRC) recurrence by developing and implementing novel microfluidics-based technology to isolate, culture, and characterize minimal residual disease (MRD)—cancer cells...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded UCSF a $724,840 Project Grant effective August 21, 2025, through July 31, 2030, under the Cancer Cause and Prevention Research program (CFDA 93.393) to investigate the relationship between persistent poverty and colorectal cancer risk through biological, behavioral, and place-based mechanisms. The research leverages existing data from two large population-based cohorts—the Multiethnic Cohort Study (MEC) and...
- Federal Grant Award Summary The University of North Carolina at Chapel Hill received a $399,829 Project Grant from the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393) to establish the feasibility of developing a population-based hepatocellular carcinoma (HCC) surveillance registry and assess the identification of at-risk patients with metabolic dysfunction-associated steatotic liver disease (MASLD). The award, effective May 15, 2026 through April...
- Federal Project Grant Award Summary Louisiana State University Health Sciences Center New Orleans received a $380,554 Project Grant from the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393) to conduct a pilot adaptive trial aimed at promoting fecal immunochemical test (FIT) screening among rural residents. The award, effective May 1, 2026 through April 30, 2028, supports the development and optimization of a novel adaptive patient navigation model...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded the University of Pittsburgh a $649,620 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) for the period May 1, 2026 through April 30, 2031. This research project addresses gaps in understanding how Medicare Advantage coverage impacts cancer care access, quality, and outcomes for older adults. The study will analyze insurance-related barriers to specialty cancer care by examining coverage...